| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/29/2013 | CA2501756C Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage |
| 01/29/2013 | CA2498315C Cytokine production-inducing antibody |
| 01/29/2013 | CA2485675C Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with disease |
| 01/29/2013 | CA2483189C Device for closure of a vascular defect |
| 01/29/2013 | CA2462984C Arrangement and method for a cassette for preparation of biological specimens |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2343929C Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/29/2013 | CA2325574C Porcine adenovirus type 3 genome |
| 01/27/2013 | CA2783825A1 Wastewater treatment system |
| 01/24/2013 | WO2013013229A1 Instrument and method for optical particle sensing |
| 01/24/2013 | WO2013013228A1 Methods for determining patient response to anti-platelet aggregation therapy |
| 01/24/2013 | WO2013013222A1 Assay to capture and detect circulating multiple myeloma cells from blood |
| 01/24/2013 | WO2013013220A2 Photonic blood typing |
| 01/24/2013 | WO2013013214A1 Method for detecting microorganisms |
| 01/24/2013 | WO2013013117A1 Network-based pathology system with desktop slide scanner |
| 01/24/2013 | WO2013013066A2 Methods for assessing genomic instabilities in tumors |
| 01/24/2013 | WO2013012997A1 Targeted osmotic lysis of cancer cells |
| 01/24/2013 | WO2013012940A1 Compensated patch-clamp amplifier for nanopore polynucleotide sequencing and other applications |
| 01/24/2013 | WO2013012924A2 Engineered microbe-targeting molecules and uses thereof |
| 01/24/2013 | WO2013012781A2 Genome-wide methylation analysis and use to identify genes specific to breast cancer hormone receptor status and risk of recurrence |
| 01/24/2013 | WO2013012749A2 Human zona pellucida glycoproteins, their oligosaccharides, and uses thereof |
| 01/24/2013 | WO2013012747A1 Rspo binding agents and uses thereof |
| 01/24/2013 | WO2013012722A1 Anti-folate receptor alpha antibodies and uses thereof |
| 01/24/2013 | WO2013012687A2 Combinations of fluorphores and pyridinium boronic acid quenchers for use in analyte sensors |
| 01/24/2013 | WO2013012498A1 Electric cell- substrate impedance sensing (ecis) of biological samples in shear stress flow |
| 01/24/2013 | WO2013012478A1 Diagnosis and treatment of autoantibody-mediated heart disease |
| 01/24/2013 | WO2013012434A1 Bioluminescent stem-loop probes, compositions containing the same and methods utilizing the same |
| 01/24/2013 | WO2013012396A1 A method and apparatus for analyzing interactions of molecules |
| 01/24/2013 | WO2013012387A1 Method for the detection of an analyte in a sample |
| 01/24/2013 | WO2013012382A1 Device and system for gas leakage detection and alarm |
| 01/24/2013 | WO2013012364A1 System and method for monitoring environmental weakening of components by monitoring atomic hydrogen permeation |
| 01/24/2013 | WO2013012223A2 Mouthpiece for breathalyzer |
| 01/24/2013 | WO2013012038A1 Method for determining depression, kit for analyzing serotonin transporter, and kit for analyzing ubiquitinated serotonin transporter in blood |
| 01/24/2013 | WO2013012028A1 Standard solution for use in analysis of amino acid in plasma |
| 01/24/2013 | WO2013011919A1 Method for evaluating nash, device for evaluating nash, program for evaluating nash, system for evaluating nash, information-communication terminal device, and method for searching for substance used to prevent or improve nash |
| 01/24/2013 | WO2013011879A1 Analytical device and analytical system |
| 01/24/2013 | WO2013011513A1 Methods of determinig enzyme activity in preserved cell samples |
| 01/24/2013 | WO2013011407A1 Interleukin-31 monoclonal antibody |
| 01/24/2013 | WO2013011381A2 Device and method for analyzing volatile organic compounds in gaseous samples |
| 01/24/2013 | WO2013011323A2 Apparatus and method for affinity assays |
| 01/24/2013 | WO2013011294A2 Diagnosis of alzheimer's disease |
| 01/24/2013 | WO2013011242A1 Novel water-soluble chromophore |
| 01/24/2013 | WO2013011236A1 Novel complexing agents and corresponding lanthanide complexes |
| 01/24/2013 | WO2013011137A1 Production and use of bacterial histamine |
| 01/24/2013 | WO2013011135A1 Ceramide c16-cer and cers6 in the treatment and diagnosis of multiple sclerosis (ms) |
| 01/24/2013 | WO2013011069A1 Device for regulating a cleaning bath for metal alloy parts |
| 01/24/2013 | WO2013011067A1 Method for evaluating the capacity of a cleaning bath containing at least one anionic or ionic surfactant to carry out a role of deoiling parts |
| 01/24/2013 | WO2013011066A1 Cleaning bath for metal alloy parts |
| 01/24/2013 | WO2013011056A2 Pathology biomarker assay |
| 01/24/2013 | WO2013011055A1 Means and methods for determining clostridial neurotoxins |
| 01/24/2013 | WO2013011011A2 Method of reversibly staining a target cell |
| 01/24/2013 | WO2013010993A1 Methods and kits for the diagnosis of alzheimer's disease |
| 01/24/2013 | WO2013010764A1 Methods and apparatus for analysis of aquatic chemical and/or biological systems |
| 01/24/2013 | WO2013010721A1 Hydrogen sensor with an active layer and method of manufacturing hydrogen sensors |
| 01/24/2013 | WO2013010553A1 Method and analytical kit for simultaneous quantification of b-complex vitamin content in food |
| 01/24/2013 | WO2013010260A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | WO2013010254A1 Biomarkers for ankylosing spondylitis |
| 01/24/2013 | WO2013010218A1 Inhibition of clathrin |
| 01/24/2013 | WO2012166700A3 Molecular profiling of a lethal tumor microenvironment |
| 01/24/2013 | WO2012164525A3 Aging biomarkers |
| 01/24/2013 | WO2012158388A3 Method and apparatus for determination of haloacetic acid ("haa") presence in aqueous solutions |
| 01/24/2013 | WO2012158000A3 Method for measuring the concentration of an atmospheric or water pollutant |
| 01/24/2013 | WO2012154745A3 Microfluidic feedback using impedance detection |
| 01/24/2013 | WO2012152747A3 Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis |
| 01/24/2013 | WO2012149006A3 Formation resistivity imager with reduced leakage to mandrel |
| 01/24/2013 | WO2012145399A3 Methods of diagnosing cancer in a patient |
| 01/24/2013 | WO2012138882A3 Micro-fluidic system using micro-apertures for high throughput detection of cells |
| 01/24/2013 | WO2012135091A3 Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and esophageal adenocarcinoma (eac) |
| 01/24/2013 | WO2012128577A3 Method for performance analysis and screening of septicaemia protein therapeutic agents |
| 01/24/2013 | WO2012096710A3 System and method for performing geochronology |
| 01/24/2013 | WO2012091506A3 Composite biomarker for the diagnosis of lung cancer, and lung cancer diagnosis method using same |
| 01/24/2013 | WO2012082742A3 Detecting cancer with anti-ccl25 and anti-ccr9 antibodies |
| 01/24/2013 | WO2012078885A3 Systems and methods for feedstock quality assessment |
| 01/24/2013 | WO2012076000A3 Method for detecting anti-nmda receptor autoantibodies for use in diagnostic procedures |
| 01/24/2013 | WO2012021753A3 Infrared camera detection systems and methods |
| 01/24/2013 | WO2011147563A9 Method for electrochemically detecting binding reactions |
| 01/24/2013 | WO2011142781A3 Pore-limit electrophoresis (ple) microchannel assays |
| 01/24/2013 | US20130024961 Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs |
| 01/24/2013 | US20130024954 Human Age-Related Neurodegenerative Nematode Model and Methods |
| 01/24/2013 | US20130024130 Blood analyzer calibration and assessment |
| 01/24/2013 | US20130024128 Method for estimating a blood sugar condition |
| 01/24/2013 | US20130023499 Certain substituted amides, method of making, and method of use thereof |
| 01/24/2013 | US20130023487 Compounds and compositions for treating infection |
| 01/24/2013 | US20130023484 Peripherin-specific autoantibodies as a marker for neurological and endocrinological disease |
| 01/24/2013 | US20130023479 Use of nucleolin as a biomarker for lymphangiogenesis in cancer prognosis and therapy |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130023473 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
| 01/24/2013 | US20130023442 Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma |
| 01/24/2013 | US20130023439 Method and Kit for Determining Sensitivity to Decitabine Treatment |
| 01/24/2013 | US20130023433 Methods of detecting nucleic acid sequences with high specificity |
| 01/24/2013 | US20130023431 Methods of Assessing Chromosomal Instabilities |
| 01/24/2013 | US20130023428 Biomarkers for neurological conditions |
| 01/24/2013 | US20130023427 Methods for assessing genomic instabilities in tumors |
| 01/24/2013 | US20130023426 Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids |
| 01/24/2013 | US20130023424 Detecting pax2 for the diagnosis of breast cancer |
| 01/24/2013 | US20130023059 Method for immobilizing streptavidin on a self-assembled monolayer |
| 01/24/2013 | US20130023058 Method and apparatus for selecting a product |
| 01/24/2013 | US20130023054 Lipid biomarkers for stable and unstable heart disease |
| 01/24/2013 | US20130023041 Method and Apparatus for Holding Cells |
| 01/24/2013 | US20130023040 Methods and apparatus for selectively processing eggs having identified characteristics |